Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-19

Clinical Trial Update: Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration [NA]

View source ↗

Summary

A clinical trial is ongoing to evaluate Quantum Molecular Resonance for neuropathic corneal pain and corneal nerve regeneration. Recruitment is currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quantum Molecular Resonance

Snippet

Sponsor: Singapore Eye Research Institute | Conditions: Neuropathic Corneal Pain | NA | Status: RECRUITING